Duncan R. Hewett
North Terrace
Adelaide, SA 5005, Australia
Adelaide, SA 5005, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Bortezomib-induced gastrointestinal dysfunction, peripheral neuropathy and neuroimmune signalling are influenced by the gut microbiota in mice.
Journal: Journal of neuroinflammation
Published: January 12, 2026
Therapeutic inhibition of myeloperoxidase with AZD5904 attenuates disease progression in mouse models of early-stage and relapsed multiple myeloma.
Journal: Haematologica
Published: December 15, 2025
Mer receptor expression promotes multiple myeloma disease development via a cell-extrinsic mechanism.
Journal: Experimental hematology
Published: January 09, 2025
Myeloperoxidase creates a permissive microenvironmental niche for the progression of multiple myeloma.
Journal: British journal of haematology
Published: May 25, 2023
Characterization of the role of Samsn1 loss in multiple myeloma development.
Journal: FASEB bioAdvances
Published: April 26, 2020
GLIPR1 expression is reduced in multiple myeloma but is not a tumour suppressor in mice.
Journal: PloS one
Published: October 17, 2019
LCRF-0006, a small molecule mimetic of the N-cadherin antagonist peptide ADH-1, synergistically increases multiple myeloma response to bortezomib.
Journal: FASEB bioAdvances
Published: August 28, 2019
Twist-1 is upregulated by NSD2 and contributes to tumour dissemination and an epithelial-mesenchymal transition-like gene expression signature in t(4;14)-positive multiple myeloma.
Journal: Cancer letters
Published: July 11, 2019
Last Updated: 09/26/2026